Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Acq. announced
Quarterly results
Auditor change
Appointed director
CC transcript
Director departure
|
|
SEELOS THERAPEUTICS, INC. (APRI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/11/2022 |
8-K
| Acquisition/merger/asset purchase announced |
| 02/18/2021 |
8-K
| Quarterly results |
| 07/30/2018 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: APRICUS BIOSCIENCES, INC., a Nevada corporation; ARCH MERGER SUB, INC., a Delaware corporation; and SEELOS THERAPEUTICS, INC., a Delaware corporation Dated as of July 30, 2018",
"APRICUS BIOSCIENCES, INC. VOTING AGREEMENT THIS VOTING AGREEMENT , dated as of July 30, 2018, is made by and among Apricus Biosciences, Inc., a Nevada corporation , Seelos Therapeutics, Inc., a Delaware corporation , and each of the undersigned holders of shares of common stock, par value $0.001 per share of Apricus or securities convertible or exercisable for shares of Common Stock . WHEREAS, Apricus, Arch Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Apricus , and the Company have entered into an Agreement and Plan of Merger and Reorganization, dated of even date herewith , providing for the merger of Merger Sub with and into the Company ; WHEREAS, Stockholder beneficially owns and has sole or shared voting power with respect to the number of Shares indicated ...",
"SEELOS THERAPEUTICS, INC. VOTING AGREEMENT THIS VOTING AGREEMENT , dated as of July 30, 2018, is made by and among Apricus Biosciences, Inc., a Nevada corporation , Seelos Therapeutics, Inc., a Delaware corporation , and each of the undersigned holders of shares of common stock, par value $0.00001 per share, of the Company or securities convertible or exercisable for shares of Common Stock . WHEREAS, Apricus, Arch Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Apricus , and the Company have entered into an Agreement and Plan of Merger and Reorganization, dated of even date herewith , providing for the merger of Merger Sub with and into the Company ; WHEREAS, Stockholder beneficially owns and has sole or shared voting power with respect to the number of Shares ind...",
"Form of CVR Agreement CONTINGENT VALUE RIGHTS AGREEMENT THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of , 2018 , is entered into by and among Apricus Biosciences, Inc., a Nevada corporation , Seelos Therapeutics, Inc., a Delaware corporation , , as representative of the holders of CVRs , and , a , as Rights Agent and as initial CVR Registrar .",
"Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System Disorders" |
|
| 03/08/2017 |
8-K
| Form 8-K - Current report |
| 11/23/2009 |
8-K
| Form 8-K - Current report |
| 02/05/2009 |
8-K
| Form 8-K - Current report |
|
|